| Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study NM Kuderer, TK Choueiri, DP Shah, Y Shyr, SM Rubinstein, DR Rivera, ... The Lancet 395 (10241), 1907-1918, 2020 | 1826 | 2020 |
| Non–small cell lung cancer: epidemiology, screening, diagnosis, and treatment N Duma, R Santana-Davila, JR Molina Mayo Clinic Proceedings 94 (8), 1623-1640, 2019 | 1591 | 2019 |
| Treatment-related adverse events of PD-1 and PD-L1 inhibitors in clinical trials: a systematic review and meta-analysis Y Wang, S Zhou, F Yang, X Qi, X Wang, X Guan, C Shen, N Duma, ... JAMA oncology 5 (7), 1008-1019, 2019 | 645 | 2019 |
| Representation of minorities and women in oncology clinical trials: review of the past 14 years N Duma, J Vera Aguilera, J Paludo, CL Haddox, M Gonzalez Velez, ... Journal of oncology practice 14 (1), e1-e10, 2018 | 323 | 2018 |
| Male breast cancer in the United States: treatment patterns and prognostic factors in the 21st century S Yadav, D Karam, I Bin Riaz, H Xie, U Durani, N Duma, KV Giridhar, ... Cancer 126 (1), 26-36, 2020 | 127 | 2020 |
| Therapy for stage IV non–small-cell lung cancer without driver alterations: ASCO living guideline N Singh, S Temin, S Baker Jr, E Blanchard, JR Brahmer, P Celano, ... Journal of Clinical Oncology 40 (28), 3323-3343, 2022 | 115 | 2022 |
| Sex differences in tolerability to anti‐programmed cell death protein 1 therapy in patients with metastatic melanoma and non‐small cell lung cancer: are we all equal? N Duma, A Abdel‐Ghani, S Yadav, KP Hoversten, CT Reed, AN Sitek, ... The oncologist 24 (11), e1148-e1155, 2019 | 98 | 2019 |
| COVID-19 vaccination and breakthrough infections in patients with cancer AL Schmidt, C Labaki, CY Hsu, Z Bakouny, N Balanchivadze, SA Berg, ... Annals of oncology 33 (3), 340-346, 2022 | 90 | 2022 |
| Evaluating unconscious bias: speaker introductions at an international oncology conference N Duma, U Durani, CB Woods, LA Kankeu Fonkoua, JM Cook, C Wee, ... Journal of Clinical Oncology 37 (36), 3538-3545, 2019 | 72 | 2019 |
| COVID-19 and cancer: a review of the registry-based pandemic response A Desai, TJ Mohammed, N Duma, MC Garassino, LK Hicks, NM Kuderer, ... JAMA oncology 7 (12), 1882-1890, 2021 | 58 | 2021 |
| It is time to talk about fertility and immunotherapy N Duma, M Lambertini The oncologist 25 (4), 277-278, 2020 | 49 | 2020 |
| Racial disparities in COVID-19 outcomes among black and white patients with cancer J Fu, SA Reid, B French, C Hennessy, C Hwang, NT Gatson, N Duma, ... JAMA network open 5 (3), e224304-e224304, 2022 | 46 | 2022 |
| Representation of minorities and elderly patients in multiple myeloma clinical trials N Duma, T Azam, IB Riaz, M Gonzalez‐Velez, S Ailawadhi, R Go The Oncologist 23 (9), 1076-1078, 2018 | 43 | 2018 |
| Characterization of comorbidities limiting the recruitment of patients in early phase clinical trials N Duma, SM Kothadia, TU Azam, S Yadav, J Paludo, J Vera Aguilera, ... The oncologist 24 (1), 96-102, 2019 | 40 | 2019 |
| The Matilda effect: underrecognition of women in hematology and oncology awards SR Patel, F St. Pierre, AI Velazquez, S Ananth, U Durani, ... The oncologist 26 (9), 779-786, 2021 | 39 | 2021 |
| Exclusion of male patients in breast cancer clinical trials N Duma, KP Hoversten, KJ Ruddy JNCI Cancer Spectrum 2 (2), pky018, 2018 | 26 | 2018 |
| Women oncologists’ perceptions and factors associated with decisions to pursue academic vs nonacademic careers in oncology EC Merfeld, GC Blitzer, A Kuczmarska-Haas, SC Pitt, F Chino, T Le, ... JAMA Network Open 4 (12), e2141344-e2141344, 2021 | 25 | 2021 |
| Disparities in the inclusion of racial and ethnic minority groups and older adults in prostate cancer clinical trials: a meta-analysis IB Riaz, M Islam, W Ikram, SAA Naqvi, H Maqsood, Y Saleem, A Riaz, ... JAMA oncology 9 (2), 180-187, 2023 | 23 | 2023 |
| Adherence to guidelines for breast surveillance in breast cancer survivors KJ Ruddy, L Sangaralingham, RA Freedman, SS Mougalian, H Neuman, ... Journal of the National Comprehensive Cancer Network 16 (5), 526-534, 2018 | 23 | 2018 |
| Commentary: race and ethnicity in biomedical research–classifications, challenges, and future directions D Idossa, N Duma, K Chekhovskiy, R Go, S Ailawadhi Ethnicity & Disease 28 (4), 561, 2018 | 21 | 2018 |
